# Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes

> **NCT01467141** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 26 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin aspart
- **DRUG:** human insulin
- **DRUG:** isophane human insulin

## Key facts

- **NCT ID:** NCT01467141
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06-19
- **Primary completion:** 2003-10-15
- **Final completion:** 2003-10-15
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01467141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01467141, "Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01467141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*